{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:56:05Z","timestamp":1785909365341,"version":"3.56.0"},"reference-count":16,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Hum Lact"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Narcolepsy, a condition adversely affecting psychological, social, and cognitive function, is more prevalent in females of childbearing age than the general population. Modafinil and armodafinil are central nervous system stimulants approved for treatment of narcolepsy. Infant exposure to these agents through human milk has not been investigated. Poor quality medication safety information during lactation is associated with early cessation of breastfeeding and suboptimal healthcare for the breastfeeding family.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Issue<\/jats:title>\n                    <jats:p>In this case study, we measured the concentration of armodafinil (the most active form of modafinil) in human milk and infant plasma to quantify infant exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management<\/jats:title>\n                    <jats:p>The participant was a 30-year-old primipara with narcolepsy, taking modafinil (300 mg morning, 100 mg noon) while breastfeeding her 6-week-old infant despite the paucity of safety information. Armodafinil concentrations were measured in eight serial human milk samples collected over a 26-hr period and in single maternal and infant plasma samples using ultra performance liquid chromatography - tandem mass spectrometry. The average concentration of armodafinil in human milk was 1.96 mg\/L; the relative infant dose was 4.85%; the theoretical infant dose was 0.294 mg\/kg\/day. Maternal and infant plasma concentrations of armodafinil were 12.02 mg\/L and 0.19 mg\/L, respectively. The participant continued to exclusively breastfeed the infant, who had normal growth and development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Based on these findings, relatively small amounts of armodafinil pass into human milk, with consequent limited infant exposure. Consideration can be given to the use of modafinil or armodafinil during breastfeeding, provided the infant is monitored. Further studies are needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08903344221134273","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:53:09Z","timestamp":1668649989000},"page":"218-222","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Infant Exposure to Armodafinil Through Human Milk Following Maternal Use of Modafinil"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-6289","authenticated-orcid":false,"given":"Catherine","family":"Leggett","sequence":"first","affiliation":[{"name":"SA Pharmacy, Women\u2019s and Children\u2019s Hospital, North Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Ritchie","sequence":"additional","affiliation":[{"name":"SA Pharmacy, Women\u2019s and Children\u2019s Hospital, North Adelaide, SA, Australia"},{"name":"SA Pharmacy, Royal Adelaide Hospital, Port Road, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Costi","sequence":"additional","affiliation":[{"name":"SA Pharmacy, Women\u2019s and Children\u2019s Hospital, North Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elliot","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arduino A","family":"Mangoni","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Flinders Medical Centre, Southern Adelaide Local Health Network, Bedford Park, SA, Australia"},{"name":"Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-2955","authenticated-orcid":false,"given":"William M.","family":"Hague","sequence":"additional","affiliation":[{"name":"Robinson Research Institute, University of Adelaide, North Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Anderson P. O. Sauberan J. B. (2016). Modeling drug passage into human milk. Clinical Pharmacology and Therapeutics 100(1) 42\u201352. https:\/\/doi.org\/10.1002\/cpt.377","DOI":"10.1002\/cpt.377"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Aurora S. Aurora N. Datta P. Rewers-Felkins K. Baker T. Hale T. W. (2018). Evaluating transfer of modafinil into human milk during lactation: A case report. Journal of Clinical Sleep Medicine 14(12) 2087\u20132089. https:\/\/doi.org\/10.5664\/jcsm.7546","DOI":"10.5664\/jcsm.7546"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Bassetti C. L. A. Adamantidis A. Burdakov D. Han F. Gay S. Kallweit U. Khatami R. Koning F. Kornum B. R. Lammers G. J. Liblau R. S. Luppi P. H. Mayer G. Pollm\u00e4cher T. Sakurai T. Sallusto F. Scammell T. E. Tafti M. Dauvilliers Y. (2019). Narcolepsy\u2014Clinical spectrum aetiopathophysiology diagnosis and treatment. Nature Reviews Neurology 15(9) 519\u2013539. https:\/\/doi.org\/10.1038\/s41582-019-0226-9","DOI":"10.1038\/s41582-019-0226-9"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-044481981-9\/50025-4"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Binns C. Lee M. Low W. Y. (2016). The long-term public health benefits of breastfeeding. Asia-Pacific Journal of Public Health 28(1) 7\u201314. https:\/\/doi.org\/10.1177\/1010539515624964","DOI":"10.1177\/1010539515624964"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Darwish M. Kirby M. Hellriegel E. T. Yang R. Robertson P.Jr. (2009). Pharmacokinetic profile of armodafinil in healthy subjects: Pooled analysis of data from three randomized studies. Clinical Drug Investigation 29(2) 87\u2013100. https:\/\/doi.org\/10.2165\/0044011-200929020-00003","DOI":"10.2165\/0044011-200929020-00003"},{"key":"e_1_3_3_8_1","volume-title":"Hale\u2019s medications & mothers\u2019 milk 2021: A manual of lactational pharmacology","author":"Hale T. W.","year":"2020","unstructured":"Hale T. W. (2020). Hale\u2019s medications & mothers\u2019 milk 2021: A manual of lactational pharmacology. Springer."},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Leggett C. Lwin E. M. P. Ritchie U. Song Y. Gerber J. P. Turner S. Hague W. M. Stark M. Upton R. Garg S. (2020). Perindopril in breast milk and determination of breastfed infant exposure: A prospective observational study. Drug Design Development and Therapy 14 961\u2013967. https:\/\/doi.org\/10.2147\/dddt.S239704","DOI":"10.2147\/DDDT.S239704"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Lwin E. M. P. Gerber C. Leggett C. Song Y. Ritchie U. Turner S. Hague W. Upton R. Garg S. (2018). Estimation of atenolol transfer into milk and infant exposure during its use in lactating women. Journal of Human Lactation 34(3) 592\u2013599. https:\/\/doi.org\/10.1177\/0890334418771308","DOI":"10.1177\/0890334418771308"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Lwin E. M. P. Leggett C. Ritchie U. Gerber C. Song Y. Hague W. Turner S. Upton R. Garg S. (2018). Transfer of rosuvastatin into breast milk: Liquid chromatography-mass spectrometry methodology and clinical recommendations. Drug Design Development and Therapy 12 3645\u20133651. https:\/\/doi.org\/10.2147\/dddt.S184053","DOI":"10.2147\/DDDT.S184053"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"McClatchey A. K. Shield A. Cheong L. H. Ferguson S. L. Cooper G. M. Kyle G. J. (2018). Why does the need for medication become a barrier to breastfeeding? A narrative review. Women and Birth 31(5) 362\u2013366. https:\/\/doi.org\/10.1016\/j.wombi.2017.12.004","DOI":"10.1016\/j.wombi.2017.12.004"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Murillo-Rodr\u00edguez E. Barciela Veras A. Barbosa Rocha N. Budde H. Machado S. (2018). An overview of the clinical uses pharmacology and safety of modafinil. American Chemical Society Chemical Neuroscience 9(2) 151\u2013158. https:\/\/doi.org\/10.1021\/acschemneuro.7b00374","DOI":"10.1021\/acschemneuro.7b00374"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"O\u2019Hara K. Wright I. M. Schneider J. J. Jones A. L. Martin J. H. (2015). Pharmacokinetics in neonatal prescribing: Evidence base paradigms and the future. British Journal of Clinical Pharmacology 80(6) 1281\u20131288. https:\/\/doi.org\/10.1111\/bcp.12741","DOI":"10.1111\/bcp.12741"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Robertson P.Jr. Hellriegel E. T. (2003). Clinical pharmacokinetic profile of modafinil. Clinical Pharmacokinetics 42(2) 123\u2013137. https:\/\/doi.org\/10.2165\/00003088-200342020-00002","DOI":"10.2165\/00003088-200342020-00002"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Scammell T. E. (2015). Narcolepsy. The New England Journal of Medicine 373(27) 2654\u20132662. https:\/\/doi.org\/10.1056\/NEJMra1500587","DOI":"10.1056\/NEJMra1500587"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Scheer D. Schwartz S. W. Parr M. Zgibor J. Sanchez-Anguiano A. Rajaram L. (2019). Prevalence and incidence of narcolepsy in a U.S. health care claims database 2008\u20132010. Sleep 42(7) 1\u201313. https:\/\/doi.org\/10.1093\/sleep\/zsz091","DOI":"10.1093\/sleep\/zsz091"}],"container-title":["Journal of Human Lactation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08903344221134273","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08903344221134273","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08903344221134273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:33:47Z","timestamp":1777502027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08903344221134273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1177\/08903344221134273"],"URL":"https:\/\/doi.org\/10.1177\/08903344221134273","relation":{},"ISSN":["0890-3344","1552-5732"],"issn-type":[{"value":"0890-3344","type":"print"},{"value":"1552-5732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}